SCHEMBL5793392

SCHEMBL5793392

Nc1c(C(=O)O)ccc(Cl)c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
FABP3 P05413 5/20 0.50
FABP4 P15090 5/20 0.50
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
MAPT P10636 2/20 0.50
THRB P10828 2/20 0.50
MAPK1 P28482 2/20 0.50
POLB P06746 2/20 0.50
LMNA P02545 2/20 0.50
RECQL P46063 1/20 0.50
FABP5 Q01469 1/20 0.50
AKR1C2 P52895 1/20 0.45
AKR1C1 Q04828 1/20 0.45
G6PD P11413 1/20 0.43
CASP7 P55210 1/20 0.43
CASP6 P55212 1/20 0.43
PRKAB2 O43741 1/20 0.42
PRKAG1 P54619 1/20 0.42
PRKAA2 P54646 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28166011 0.86 ALDH1A1 (0.47) ALDH1A1FABP3FABP4KMT2AMEN1
SCHEMBL5820920 0.83 FABP3 (0.54) ALDH1A1FABP3FABP4FABP5AKR1C2
SCHEMBL15057790 0.82 MEN1 (0.50) ALDH1A1FABP3FABP4KMT2AMEN1
SCHEMBL30848253 0.81 ALDH1A1 (0.53) ALDH1A1FABP4KMT2AMEN1MAPT
SCHEMBL2462914 0.80 MEN1 (0.60) ALDH1A1FABP3FABP4KMT2AMEN1
SCHEMBL15060463 0.80 CASP7 (0.53) ALDH1A1FABP4KMT2AMEN1MAPT
SCHEMBL3824310 0.80 ALDH1A1 (0.51) ALDH1A1FABP4KMT2AMEN1MAPT
SCHEMBL18980394 0.77 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1MAPTTHRB
SCHEMBL28992361 0.76 KMT2A (0.55) ALDH1A1FABP3FABP4KMT2AMEN1
SCHEMBL31037493 0.76 FABP3 (0.68) ALDH1A1FABP3FABP4KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006022955-A2 TOPOISOMERASE INHIBITORS PROPHARMACON, INC. (US) 2006-03-02 WO disclosed